For the Inventor, By the Inventor

Enter assignee name

Bothell, WA, United States of America

Darwin Discovery Limited

USPTO Granted Patents = 90

% Expired Patents = 25.6

CIPO Patents = 3

EPO Patents = 1

Forward Citations = 1,080

Loading Chart...

Loading Chart...

70 inventors (with patents filed for the assignee):

John Gary Montana (39 out of 68 patents)

Andrew Douglas Baxter (30 out of 44 patents)

David Alan Owen (24 out of 28 patents)

4. Hazel Joan Dyke (20 out of 30 patents)

5. Robert John Watson (17 out of 20 patents)

6. Mary E Brunkow (13 out of 23 patents)

7. Andrew Sharpe (8 out of 30 patents)

8. David J Galas (7 out of 18 patents)

9. Bryan W Paeper (7 out of 13 patents)

10. Verity Margaret Sabin (7 out of 11 patents)

11. Jeffrey Van Ness (7 out of 35 patents)

12. Duncan Robert Hannah (7 out of 7 patents)

13. Brian Robert Kovacevich (7 out of 67 patents)

14. John Thomas Mulligan (7 out of 32 patents)

15. Fred Ramsdell (6 out of 11 patents)

Core Competencies:

Bone Mineralization

Hydroxamic Acid Derivatives

MMP Inhibitors

Peptidyl Compounds

Levobupivacaine

Heterocyclic Compounds

Analgesic Agents

Therapeutic Uses

Gene Identification

Biological Compositions

Carboxylic Acid Derivatives

Drug Formulations

90 patents: Sort by Forward Citations

1. 7994299 - Compositions and methods for increasing bone mineralization (2011-08-09),

2. 7977312 - Compositions and methods for increasing bone mineralization (2011-07-12),

3. 7758858 - Antibodies associated with alterations in bone density (2010-07-20),

4. 7192583 - Methods for modulating bone mineralization (2007-03-20),

5. 6933306 - Hydroxamic and carboxylic acid derivatives (2005-08-23),

6. 6884618 - Identification of the gene causing the mouse scurfy phenotype and its human ortholog (2005-04-26),

7. 6818622 - Selective MMP inhibitors having reduced side-effects (2004-11-16),

8. 6809100 - Hydroxamic acid derivatives (2004-10-26),

9. 6803453 - Antibodies associated with alterations in bone density (2004-10-12),

10. 6794145 - Identification of the gene causing the mouse scurfy phenotype and its human ortholog (2004-09-21),

11. 6787536 - Hydroxamic acid derivatives (2004-09-07),

12. 6734189 - Hydroxamic and carboxylic acid derivatives (2004-05-11),

13. 6706719 - Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity (2004-03-16),

14. 6683171 - Identification of the gene causing the mouse scurfy phenotype and its human ortholog (2004-01-27),

15. 6683160 - Antibodies specific for Fkhsf gene products (2004-01-27),

Darwin Discovery Limited is a leading biotechnology company that specializes in discovering innovative drug treatments. Our team of expert scientists and researchers is devoted to the exploration of novel therapies to address unmet medical needs. Through cutting-edge technology and advancements in drug discovery, we aim to improve the lives of patients around the world. Visit our website to learn more about our groundbreaking solutions and ongoing research projects.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

90 Patents

#5 in Bothell, WA

#73 in Washington

#4,145 in US

#8,513 in the World

Bothell, WA, United States of America

Darwin Discovery Limited

Forward Citations = 1,080

70 inventors:

John Gary Montana (39 out of 68 patents)

Andrew Douglas Baxter (30 out of 44 patents)

David Alan Owen (24 out of 28 patents)

4. Hazel Joan Dyke (20 out of 30 patents)

5. Robert John Watson (17 out of 20 patents)

Please report any incorrect information to [email protected]

Loading…